Introduction {#Sec1}
============

Oxygen is essential for life. As has any drug, it has consequences in case of under- and overdosing. In adult intensive care patients, hypoxemia is a primary preoccupation for all clinicians. The consequences of hyperoxemia are more often neglected because they have been poorly explored. Several clinical observations have suggested that liberal administration of oxygen can be toxic \[[@CR1]--[@CR3]\]. Hyperoxia induces the constitution of free oxygen radicals that may cause endothelial cell injury and increases the presence of inflammatory cells \[[@CR4]\]. It can lead to absorption atelectasis in lung regions with low ventilation-to-perfusion ratios \[[@CR5]\]. In adult intensive care patients, it has been shown that exposure to hyperoxemia may be harmful in specific populations. In post-cardiac arrest patients, arterial hyperoxemia was independently associated with in-hospital mortality, to an extent comparable to hypoxemia \[[@CR6]\]. In nonventilated severe COPD patients with exacerbation, high FiO~2~ can be responsible for hypercapnia but also increased mortality \[[@CR7]\]. In patients with severe traumatic brain injury, hyperoxemia is associated with increased mortality and worse outcomes \[[@CR8]\].

Based on these concerns and the possibility that optimizing oxygenation targets may improve patients' outcome, systems for automatic adjustment of FiO~2~ based on SpO~2~ measurement might be of great value to optimize care. With the use of pulse oximetry and computer technology, several attempts have been made to automate the adjustment of FiO~2~, especially in neonatology, because of the frequent and unpredictable change of oxygenation and risks of hyperoxemia in premature babies \[[@CR9]--[@CR12]\]. In adults, preliminary attempts at closed-loop control of oxygenation were developed and used in military trauma patients, as well as for titrating the FiO~2~ for COPD patients requiring long-term oxygen therapy \[[@CR13]--[@CR15]\]. These systems proved a reduction in oxygen use without inducing hypoxemia compared with conventional adjustments. Recently, an automated oxygen-flow titration was tested on healthy subjects during induced hypoxemia and showed a significant reduction of hypoxemia and hyperoxemia compared with classic constant-flow oxygen administration \[[@CR16]\]. Last, a recent mode of ventilation allows full control of both pressure-targeted breaths and the level of FiO~2~ in a closed-loop manner. Two recent clinical studies showed the feasibility of this technique \[[@CR17], [@CR18]\].

To overcome the challenges of continuously maintaining an adequate oxygenation in adult ICU patients, we developed an automated oxygen-controller prototype that aims to maintain the measured SpO~2~ in a predefined target range \[92% to 96%\]. For this system, we defined two different FiO~2~-SpO~2~ feedback profiles with the hypothesis that the more-severely hypoxemic patients, because of intrapulmonary shunt, are less sensitive to FiO~2~ changes and need larger changes in FiO~2~ than do less-hypoxemic patients. The first aim of the current study was to test and compare these two different SpO~2~-FiO~2~ profiles in patients with different degrees of hypoxemia to maintain SpO~2~ in the predefined target range \[92% to 96%\]. To evaluate the clinical impact of the system, we also compared the results obtained with these two profiles of the FiO~2~ controller with usual care based on a comparable historical control group.

Materials and methods {#Sec2}
=====================

Study design and patients {#Sec3}
-------------------------

The study was conducted in the medical-surgical ICU of Geneva University Hospital. The first part of the study was a prospective trial performed in 20 ICU patients, and the second part included a retrospective analysis of consecutive admitted patients between September and October 2011 in the same ICU. The two parts of the study were accepted by the Ethics Committee of the hospital \[The Ethic Committee and Research on Human Beings (CEREH), research project number 12089(NAC12040)\].

For the first part, signed informed consents were obtained from the patient when possible or from the family, and from the attending physician. For both parts, inclusion criteria were similar and mechanically ventilated patients for more than 48 hours after ICU admission older than 18 years old. Patients with severe acidosis (pH ≤7.20), hemodynamic instability, serum lactate \> 3mmol/L, or need for norepinephrine infusion ≥0.5 μg/kg/min, pregnant, or with intracranial hypertension were not included. Concerning the second part, SpO~2~ had to be recorded continuously to ensure the selection of the patient for the control group.

The automated FiO~2~ controller {#Sec4}
-------------------------------

The FIO~2~-controller prototype tested in the present study included software implemented in a medical PC connected via RS-232 serial links to a ventilator (Evita XL; Dräger Medical, Lübeck, Germany) and to a pulse oximeter (Radical 7; Masimo Corp, Irvine, CA, USA) set at an averaging interval of 2 seconds. A probe was placed on the finger of the patient while we used an ear probe in case of poor perfusion, as indicated by the perfusion index of the Masimo. The perfusion index (PI) which is the ratio of the pulsatile blood flow to the nonpulsatile or static blood in peripheral tissue, was calculated continuously by the Masimo. A threshold of low signal and unreliable measurement was defined as signal index quality (SIQ) \<0.30, where the latter represents Masimo's quality indicator in case of extremely low perfusion and motion conditions \[[@CR19]\]. When SIQ was \<0.30, the FiO~2~ controller kept the last FiO~2~ before this low SIQ value.

The serial link connected to the pulse oximeter allowed a continuous recording of SpO~2~ values, as well as heart rate, perfusion index, SIQ, and SpO~2~ alarms every second. With the same frequency, FiO~2~ values measured on the inspiratory nozzle and set on the ventilator were acquired from the ventilator. The proposed FiO~2~ adjustments were indicated by an acoustic signal and displayed on the screen of the medical PC every 30 seconds. The purpose of the present study was to test the reliability of the system working in an open loop. To achieve this goal, a fully dedicated ICU research nurse executed the adjustments on the ventilator. He could deviate from any proposal if it was considered to be unsafe, according to his clinical judgment.

The target for the controller is the midpoint between the high (96%) and low (92%) SpO~2~ targets (that is, 94%). The automatic FiO~2~ controller compares the measured SpO~2~ with the target 94% and calculates the difference to control the delivered FiO~2~ set to the patient.

The delivered FiO~2~ depends on the selected version of the algorithm. These latter are two tables that define for each SpO~2~ deviations (ΔSpO~2~) an FiO~2~ step change (either increase or decrease) to be applied to the current FiO~2~. These two different tables define the two slopes of SpO~2~-FiO~2~ tested in this study. The difference is based on the fact that we hypothesized that, for severely hypoxemic patients, a larger change or step in FiO~2~ is required than for less-hypoxemic patients because intrapulmonary shunt makes those patients less "sensitive" to FiO~2~ changes.

After changing FiO~2~, a predefined time of 30 seconds has to expire before changing FiO~2~ is allowed. To react immediately in case of a severe hypoxemic event, the controller applies 100% of FiO~2~ when SpO~2~ \<85%. This reaction is the same in the two versions of the algorithm.

For avoiding instabilities (that is, oscillations, overshoots), the reaction of the FiO~2~ controller is dampened based on physiological and technical delays. Because of this dampening of the controller, early adjustments every 30 seconds were possible. The controller is based on a conventional Proportional-Integral-Derivative (PID) control using both the SpO~2~-FiO~2~ slopes and ΔFiO~2~ step changes, based on an estimated effective FiO~2~.

Study protocol {#Sec5}
--------------

The study was composed of two parts: a prospective trial and a retrospective analysis.

### First part, prospective trial {#Sec6}

The first part of the study consisted of a prospective crossover trial that aimed to compare the usefulness of two feedback open-loop profiles for the FiO~2~ controller. The trial corresponded to two 3-hour periods applied in randomized order, with FiO~2~ adjusted according to each profile by a research nurse. As the main difference between the two profiles is the SpO~2~/FiO~2~ slope, we tested the clinical difference of using these two different slopes. During all study periods, the SpO~2~ target range was 92% to 96%. This range was consistent with previous clinical publications on automatic FiO~2~ controllers \[[@CR13], [@CR14], [@CR16], [@CR20]\]. It was considered a reasonable compromise that combines safety (limiting risk of hypoxemia) and efficacy to limit FiO~2~ in comparison to usual care, and which was also used in the control ICU. This was important for the comparison between the two groups in the study (study group and historical control group). A research nurse was fully dedicated for the FiO~2~ adjustments and remained at the bedside during each trial. Meanwhile, patients continued to receive usual care and ventilator parameters such as positive end-expiratory pressure (PEEP), were kept constant unless the clinician asked for changes. In two patients, a change of PEEP was required.

All patients were ventilated with the same ventilator (Evita XL) and were randomly allocated to an order for the two profiles by opening a sealed envelope. During the recordings, endotracheal suctioning could be needed. Before any suctioning, FiO~2~ was increased to 100%. This was obtained automatically in the first five patients (preoxygenation procedure function of the ventilator). However, this approach was not consistently used by the nurses because it was not a systematic standard approach for all patients. Therefore, we decided to recommend doing it manually in the 15 other patients, with FiO~2~ subsequently decreased by following the FiO~2~ controller suggestions. These episodes produced major changes in FiO~2~ and SpO~2~ (especially in the high range) over a short period, introducing noise in the signal and reducing the sensitivity of the comparison. We decided against keeping it in the comparison because we were expecting only small changes between the two profiles. We therefore removed for the comparison of the two profiles a period of 15 minutes for each episode of suctioning (it usually took between 5 and 10 minutes to come back to the preceding level) corresponding to the preoxygenation and suctioning maneuvers.

For each patient, we selected the blood gases and ventilation parameters measured at baseline (in the morning). The 20 patients were separated into two groups of 10 according to the median PaO~2~/FiO~2~ ratio: a moderately hypoxemic group with PF \>188 mm Hg and a severely hypoxemic group with PF ≤188 mm Hg.

### Second part {#Sec7}

The second part of the study consisted of a retrospective data collection of an historical group composed of 30 patients admitted in the ICU before the start of the clinical protocol and ventilated at least 48 hours. The nurse:patient ratio during this period was 1:1 or 1:2, depending on the severity of the patient's condition. Concerning FiO~2~ adjustments in the ICU, no explicit limitations were placed on the usual care, except a prescribed low SpO~2~ threshold for all patients. Thus, FiO~2~ settings in the historical control group were dependent on the physician or nurse in charge and could be reduced to 21% if necessary. Data were collected from a patient data-management system (Centricity Critical Care Clinisoft GE Healthcare) over three different periods of 6 hours (at admission, after 24 hours, at day 7). In this group, SpO~2~ values were recorded every 1 to 2 minutes. We were especially interested to the data obtained after 24 hours and at day 7, because our patients in the first part were studied after several days of mechanical ventilation. Patients' identifying information was removed to keep them completely anonymous. In this control group, a subgroup of 17 patients had a minimal clinical threshold of SpO~2~ ≥92% specifically ordered by the clinician until the day 7 after admission; this subgroup was also compared with the FiO~2~ controller because the latter has the same low threshold for SpO~2~.

We could not precisely identify the suctioning periods in the control group, and therefore, for this analysis, suctioning maneuvers, and preoxygenation periods were kept in both groups (study group and the historical control group) for the analysis. For the control group, SpO~2~ was measured with a pulse-oximetry system (Intellivue MP70 monitor; Philips Medical Systems, Amsterdam, The Netherlands). SpO~2~ data recorded from the system contained very low values, which carried a high probability of not being real. This hypothesis was confirmed when compared with Masimo's recordings, in which SpO~2~ values were almost always ≥80%. We therefore defined aberrant values as SpO~2~ \<80% as corresponding to erroneous measurements or artifacts, and we removed them from all the recordings of this group.

Patient data and analysis {#Sec8}
-------------------------

For both groups, we collected the same baseline characteristics including the Acute Physiology and Chronic Health Evaluation (APACHE) II and the Simplified Acute Physiology Score (SAPS) II at the day of admission. Blood gases and care procedures were documented from nursing and medical records. The first arterial blood gases at the day of admission for the historical group and in the morning for the study group were selected to define the baseline values of pH, PaO~2~, PaCO~2~, SaO~2~, and to calculate the PaO~2~/FiO~2~ ratio. Ventilator settings and modes in addition to monitored measurements, including SpO~2~ and FiO~2~, were recorded.

Times with SpO~2~ above, within, and below the target range \[92% to 96%\] were reported as percentage of the recorded time. These latter defined, respectively, hyperoxemia (SpO~2~ ≥97%), normoxemia (SpO~2~ ≥92% and SpO~2~ ≤96%), and hypoxemia (SpO~2~ ≤91%). These percentages of time were used to compare the two profiles in the first part of the study and to compare the FiO~2~ controller and the control groups in the second part. The differences between the two slopes studied in the first part of the study were considered small enough to justify grouping together all data obtained with the FiO~2~ controller. The percentage of time spent within the target range was the primary outcome variable of efficacy, and the percentage of time spent outside the target was the outcome variable of safety.

Statistical analysis {#Sec9}
--------------------

Statistical analysis was performed by using SPSS (SPSS 16.0; SPSS Inc, Chicago, IL, USA). Descriptive statistics (median and 25th and 75th percentiles) were used to summarize demographic characteristics and ventilation and blood gases baseline values. SpO~2~ percentages were presented as means with standard deviations. In the first part of the study, a Mann-Whitney *U* test was used to determine whether baseline characteristics (ventilation, blood gases, scores) were significantly different between the two groups of 10 patients separated on the median value of the PaO~2~/FiO~2~ ratio. We performed pairwise comparisons by using the Wilcoxon test to compare the two profiles in each group. In the second part, a *t* test was used to determine the significance of the difference between the study group and the historical group.

Results {#Sec10}
=======

First part {#Sec11}
----------

### Patients {#Sec12}

Twenty-two patients were enrolled in the study (sixteen men and six women), and two patients could not complete the study (the first one experienced self-extubation after 2 hours of recordings, and the second one's condition was severely worsened before starting the trial). All 20 patients tolerated the adjustments and completed both tests. We classified the 20 included patients into two categories of hypoxemia, according to their median PaO~2~/FiO~2~ ratio. Table [1](#Tab1){ref-type="table"} describes the characteristics of the two groups. They were comparable except for an older age in the moderately hypoxemic patients. Table [2](#Tab2){ref-type="table"} shows ventilation parameters and arterial blood gases. Tidal volume was higher and FiO~2~ lower in the moderately hypoxemic patients. For arterial blood gases, only oxygenation was significantly different between the two groups (*P* \< 0.001).Table 1**Baseline characteristics of the patients**VariableSevere hypoxemiaModerate hypoxemiaΡ value(***n*** = 10)(***n*** = 10)Age, years65 (49-69)76 (72-83)0.029Sex, male/female7/37/3Height, cm175 (171-183)170 (161-177)0.190Weight, kg71 (66-77)66 (58-75)0.315Heart rate, beats per minute88 (74-105)84 (75-96)0.393APACHE II, at ICU admission27 (24-30)31 (26-33)0.165SAPS II, at ICU admission53 (51-58)56 (43-66)0.684SOFA, at day of recording7 (7-9)11 (9-13)0.052RASS, at day of recording-4 (-4 to -1)-1 (-3 to -1)0.631Mechanical ventilation, days4 (2-7)3 (1-5)0.393ICU stay, days4 (2-7)4 (1-8)0.579**Respiratory diagnosis,** ***n*** **(%)**Pneumonia3 (23)1(10)Acute pulmonary edema1 (8)0 (0)COPD4 (31)2 (20)ARDS3 (23)0 (0)Other2 (15)7 (70)**Equipment,** ***n***Endotracheal tube/tracheostomy9/19/1Diameter of the tube, mm8.0 (7.5-8.0)7.5 (7.5-8.0)0.165APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; SAPS, Simplified Acute Physiology Score; RASS, Richmond Agitation Sedation Scale. ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease. "Other" patients had cardiogenic shock (three), cardiac surgery, spine surgery, cardiorespiratory arrest, or liver failure. One patient could be considered to have a normal lung.Table 2**Ventilation and arterial blood gases of the patients**VariableSevere hypoxemiaModerate hypoxemiaΡ value(***n*** = 10)(***n*** = 10)**Ventilator mode at study inclusion, n (%)**Pressure support ventilation14 (70)14 (70)Pressure control ventilation3 (15)5 (25)Volume assist control ventilation2 (10)1 (5)Synchronized Intermittent Mandatory Ventilation1 (5)0 (0)**Ventilator settings (in the morning)**MV exp,vL10 (10-12)8 (7-10)0.123Tidal volume, ml/kg predicted body weight7 (6-8)9 (7-10)0.011Positive end-expiratory pressure, cm H~2~O5 (5-7)7 (5-8)0.393Peak inspiratory pressure, cm H~2~O20 (17-25)22 (18-25)0.853Inspired fraction of oxygen, %40 (40-45)30 (25-35)0.001**Arterial blood gases (in the morning)**pH7.45 (7.39-7.48)7.40 (7.38-7.44)0.247PaO~2~, mm Hg69 (63-71)76 (72-79)0.005PaCO~2~, mm Hg38 (35-54)39 (35-42)0.796SaO~2~, %94 (93-95)97 (96-97)0.001PaO~2~/FiO~2~, mm Hg160 (133-176)239 (201-285)\<0.001

### Hypoxemia, normoxemia, and hyperoxemia {#Sec13}

Figure [1](#Fig1){ref-type="fig"} shows an example of a patient's recording: normoxemia was maintained by the FiO~2~ controller during 98.0% of the recording time; hyperoxemia represented 2.0%, and hypoxemia, 0.1%. FiO~2~ set by the research nurse and suggested by the FiO~2~ controller were continuously recorded. More than 98% of the time, the research nurse followed the FiO~2~-controller suggestions.Figure 1**Example of a patient's recording over a 3-hour period, displaying five signals respectively described from top to bottom: SpO** ~**2**~ **levels over time (blue line, bold); FiO** ~**2**~ **steps set by the nurse (purple) and proposed by the FiO** ~**2**~ **controller (red); at the bottom, heart rate (grey) and perfusion index (purple) from Masimo.** Please note that the grey circles indicate an example in which FiO~2~ set and FiO~2~ proposed were slightly divergent: this indicated a situation in which the nurse did not fully follow the FiO~2~-controller's suggestions.

Table [3](#Tab3){ref-type="table"} compares the amount of time that patients spent within and outside the target SpO~2~. Periods corresponding to an absence of signal and when it was not valid were also recorded. According to these criteria, we compared the two profiles (slopes of response designed for severely hypoxemic and moderately hypoxemic patients) in each group.Table 3**Percentage of time spent in different SpO** ~2~ **ranges in each group according to the two controller profiles**GroupSevere hypoxemia groupModerate hypoxemia group(***n*** = 10)(***n*** = 10)SH-profileMH-profile***P*** valueSH-profileMH-profile***P*** value**Time with no signal (%)**0.1 ± 0.20.1 ± 0.20.6860.4 ± 0.50.1 ± 0.10.050**Time with SIQ ≤ 0.3 (%)**0.1 ± 0.20.1 ± 0.21.0000.3 ± 0.60.0 ± 0.00.072**Time with hypoxemia (SpO** ~**2**~ **≤ 91%) (%)**1.7 ± 2.21.9 ± 1.90.8591.2 ± 1.01.0 ± 1.00.721**Time with normoxemia (SpO** ~**2**~ **(92% to 96%)) (%)**96.7 ± 4.295.2 ± 4.80.04795.1 ± 4.297.3 ± 2.80.074**Time with hyperoxemia (SpO** ~**2**~ **≥ 97%) (%)**1.4 ± 2.12.8 ± 3.00.0593.0 ± 3.01.6 ± 2.10.074SIQ, Signal Index Quality; SH, severely hypoxemic; MH, moderately hypoxemic.

The percentage of time spent in the target range was higher than 95% in all cases. The severely hypoxemic profile was slightly better (*P* \< 0.05) for the more-hypoxemic patients (PaO~2~/FiO~2~ \< 188) to keep them in normoxemia. The number of suctioning episodes were calculated in each group and reported in Additional file [1](#MOESM1){ref-type="media"}: Table S1. For these maneuvers, no specific protocol was defined.

Second part {#Sec14}
-----------

### Patients {#Sec15}

Thirty patients were included in the analysis for the control group. All patients were mechanically ventilated within the first 24 hours after ICU admission. Data about severity of illness, respiratory diagnosis, and demographic characteristics are given in Additional file [2](#MOESM2){ref-type="media"}: Table S2. A subgroup of 17 patients had a prescribed lower SpO~2~ threshold of 92% (that is, identical lower SpO~2~ threshold than with the FiO~2~ controller), and was also analyzed separately from the historical group. Additional file [3](#MOESM3){ref-type="media"}: Table S3 presents ventilation and blood gases for both groups.

### Group comparison {#Sec16}

We compared the study group with the historical groups to assess the efficiency of the FiO~2~ controller in maintaining the SpO~2~ within the target range and reducing time in hyperoxemia and hypoxemia. For both historical groups, we selected three periods of 6 hours: after admission in the ICU, after 24 hours, and after 7 days (*n* = 25), and the results are presented in Figures [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}, which illustrate the distribution of the time spent in the different SpO~2~ ranges in the FiO~2~ controller group and in the control groups. All comparisons between the study group and both historical groups were significant, showing a shorter time spent both in hyperoxemia and in hypoxemia with the automatic FiO~2~ controller (see Additional file [4](#MOESM4){ref-type="media"}: Table S4). In the historical group, a slight decrease in hypoxemia (SpO~2~ ≤91%) and hyperoxemia (SpO~2~ ≥97%) periods was found after 7 days after admission compared with the other two periods.Figure 2**Percentages of time within the predefined SpO** ~**2**~ **ranges during three periods (first 6 hours after admission, after 24 hours, and after 7 days) in the historical group compared with the study group.**Figure 3**Percentages of time within the predefined SpO** ~**2**~ **ranges during three periods (first 6 hours after admission, after 24 hours, and after 7 days) in the historical subgroup with a lower SpO** ~**2**~ **threshold at 92% compared with the study group.**

Discussion {#Sec17}
==========

The study showed that a specific open-loop FiO~2~ controller is able to maintain SpO~2~ reliably within a predefined target range. The time spent in the defined range is much higher than in clinical practice, because of reduced time both in hyperoxemia and in hypoxemia. Although differences between the two FiO~2~-SpO~2~ slopes of responses are relatively small, each profile was well adapted to each category of patients.

The historical group in our study, in accordance with the literature, suggests that the situation of oxygenation control can be improved. In ICUs, considerable variations exist in the attitude toward oxygen management. A survey among New Zealand and Australian intensivists showed a large variation in practices \[[@CR21]\]: for instance, for a ventilated acute respiratory distress syndrome patient, 37% of respondents would not allow SaO~2~ of \<85% for ≤15 minutes, and 28% would not allow SaO~2~ \<90% for \>24 hours. Hypoxemia is a major concern to clinicians, whereas hyperoxemia is often left out of consideration. A Canadian questionnaire study showed that most respondents prevent much more hypoxemia than hyperoxemia \[[@CR8]\]. A recent Dutch study \[[@CR22]\] showed that, in terms of minimizing hyperoxemia, intensivists are simply guided by reducing FiO~2~ to levels presumed to be nontoxic, with little concern for PaO~2~ level.

Several recent clinical observations have, however, suggested that liberal administration of oxygen can be toxic. In an observational multicenter study concerning patients admitted after resuscitation from cardiac arrest, those exposed to hyperoxemia (PaO~2~ ≥300 mm Hg) experienced increased mortality compared with both normoxemic and hypoxemic groups (PaO~2~ \<60 mm Hg) \[[@CR2]\]. Administering supplemental oxygen to coronary heart disease (CHD) patients with the goal of maintaining 100% saturation might result in vasoconstriction in the coronary circulation and hemodynamic instability \[[@CR3]\]. In a general ICU population, both low PaO~2~ and high PaO~2~ during the first 24 hours after ICU admission were associated with hospital mortality, forming a U-shaped curve \[[@CR1]\].

Another study found only an association between hypoxemia and increased in-hospital mortality \[[@CR23]\]. Recently, Rachmale et al. \[[@CR24]\] evaluated prospectively the electronic medical record screening of 289 ICU patients with acute lung injury to assess excessive oxygen exposure and its effect on pulmonary outcomes. Excessive FiO~2~ was defined as FiO~2~ \>0.5, despite SpO~2~ \>92%, and results showed that 74% of the included patients were exposed to it. The authors demonstrated a correlation between prolonged FiO~2~ exposure and worsening of oxygenation index at 48 hours and an association with longer duration of mechanical ventilation and ICU stay.

In our study, the potential of the automatic controller is best shown with the comparison of the time spent in hypoxemia with the historical subgroup. This subgroup had a prescribed lower SpO~2~ threshold of 92%, but no upper limitation. The FiO~2~ controller showed better results in preventing hypoxemia, at the same time, keeping the time with hyperoxemia to a minimum and thus maximizing time in normoxemia.

In accordance with current ICU practice, the monitoring of oxygenation was based on pulse oximetry that continuously and noninvasively measures SpO~2~. Pulse oximetry has been shown to be a reliable technique for measuring the oxygen level and reduces the frequency of blood gas analysis \[[@CR25]--[@CR28]\]. Pulse oximetry has limitations, as, for example, artifacts due to patient motion, and low perfusion \[[@CR29], [@CR30]\]. Among pulse-oximetry technologies, Signal Extraction Technology, as used by Masimo, seems to have superior performance compared with other pulse-oximetry technologies in terms of motion and artifact, false alarms, and data dropout \[[@CR31]--[@CR34]\]. In neonatology, such technology has been shown helpful in reducing severe retinopathy of prematurity in preterm infants treated with supplemental oxygen \[[@CR35]\].

With the use of pulse oximetry and computer technology, several attempts have been made to automatize the adjustment of FiO~2~, especially in neonatology because of the frequent and unpredictable change of oxygenation and risks of hyperoxemia in premature babies \[[@CR9]--[@CR12], [@CR19], [@CR36]\]. This automation has rarely been proposed to adults to guide the clinician to the most appropriate FiO~2~, apart from research. A closed-loop control of oxygenation used in military trauma patients demonstrated its efficiency at reducing oxygen needs and showed that even severely injured trauma patients can be managed with FiO~2~ \<0.30 \[[@CR37]\]. Rees *et al*. \[[@CR38]\] created a decision support system that provides advice about FiO~2~ setting, tidal volume, and frequency rate based on physiological models. The system has been tested retrospectively and prospectively in a few patients to evaluate its ability to provide appropriate FiO~2~ suggestions and has shown better FiO~2~ selection in comparison with attending clinicians in intensive care patients \[[@CR39], [@CR40]\]. A system that automatically controls oxygen administration during nasal oxygen therapy has been proposed, based on SpO~2~ measurements \[[@CR16]\]. A fully controlled ventilation system was also compared with usual care in a randomized controlled trial of postoperative patients after cardiac surgery \[[@CR18]\]. Both ventilation and FiO~2~ were automatically controlled with a target for SpO~2~ of 94% to 98%. The patients in the automated ventilation arm spent less time in nonacceptable ventilation zones, but very few details were specifically given concerning oxygenation.

We adapted an open-loop inspired oxygen control system for use in adults that has been recently tested successfully on intensive care neonates used in a closed-loop manner \[[@CR41]\]. We designed two profiles, with the hypothesis that the more-hypoxemic patients, as defined by the lowest PaO~2~/FiO~2~ ratio, would be less sensitive to FiO~2~ changes because of intrapulmonary shunt. This was confirmed in the clinical study, although the differences between the two slopes were modest. A clinician could use the classic threshold of 200 mm Hg of PaO~2~/FiO~2~ ratio to select the best slope, but if the other slope were to be selected, the results would remain safe.

Limits of the study {#Sec18}
-------------------

First, the automated FiO~2~-controller prototype tested in the present study presents some technologic limits because it depends on the reliability and the accuracy of SpO~2~ and adjusts only the FiO~2~. It does not adjust the PEEP level, for instance. Such a system must also contain alarms alerting the clinician when consistent and substantial changes in FiO~2~ are observed; otherwise, a risk would be to reduce the attentiveness of the caregiver and delay recognition of changes in respiratory function. These alarms were not specifically tested with the open loop. We excluded patients with hemodynamic instability to limit the risk of deterioration of the patient and did not face any problem because of low signal-quality measurement. The controller algorithm is also able to validate the SpO~2~ signal quality and enters into a fall-back state, keeping FiO~2~ constant. This condition must be investigated to test the reliability of the system in extreme conditions. Last, the experimental design gave us the unique opportunity to compare the system with usual care but could not permit us to assess the workload reduction expected with the automatic system. The 6-hour period tested in the present study is relatively short. When we investigated different time windows in the control group, however, they all looked very similar, suggesting that these 6-hour periods are meaningful and representative.

Conclusion {#Sec19}
==========

The tested open-loop system allowed maintaining SpO~2~ within a target range and decreased hyperoxemia and hypoxemia periods in comparison with usual care. It could provide physiological and clinical benefits to patients. As with every automated system, it requires an understanding of its operation and vigilance. This study opens the perspective for a test in a closed loop in comparison with usual care.

Key messages {#Sec20}
============

An automated FiO~2~ controller based on oxygen-saturation measurement is able to maintain SpO~2~ reliably in a safety-predefined range during mechanical ventilation of adult critically ill patients.The Automatic FiO~2~ controller exhibits excellent performance in adjusting FiO~2~ at different levels of baseline PaO~2~/FiO~2~ ratio.Automatic adjustment of FiO~2~ was able to maintain SpO~2~ in a predefined target range much better compared with a historical group of mechanically ventilated patients.
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APACHE II

:   Acute Physiology and Chronic Health Evaluation II

ARDS

:   acute respiratory distress syndrome

COPD

:   chronic obstructive pulmonary disease

FiO2

:   fraction of inspired oxygen

ICU

:   intensive care unit

MH

:   moderately hypoxemic

PaCO2

:   carbon dioxide partial pressure

PaO2

:   arterial oxygen partial pressure

PaO2/FiO2 ratio

:   ratio of arterial oxygen partial pressure to fraction of inspired oxygen

PEEP

:   positive end-expiratory pressure

RASS

:   Richmond Agitation Sedation Scale

SaO2

:   arterial oxygen saturation

SAPS II

:   Simplified Acute Physiology Score II

SH

:   severely hypoxemic

Signal IQ

:   Signal Index Quality

SpO2

:   arterial oxygen saturation by pulse oximetry.
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